France· FR:64798803
JCOVDEN, suspension injectable Vaccin contre la COVID-19 (Ad26.COV2-S [recombinant])
A medicinal product containing adénovirus type 26 codant pour la glycoprotéine spike du sars-cov-2, registered in France by JANSSEN CILAG INTERNATIONAL NV.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ADÉNOVIRUS TYPE 26 CODANT POUR LA GLYCOPROTÉINE SPIKE DU SARS-COV-2
- Manufacturer
- JANSSEN CILAG INTERNATIONAL NV
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip13340093022223210 flacons multidoses en verre de 5 doses
- cip13340093022701520 flacons multidoses en verre de 5 doses
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Adénovirus type 26 codant pour la glycoprotéine spike du sars-cov-2 in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a8c453db-7997-4825-863f-082b8dddee67 GET /v1/drugs/a8c453db-7997-4825-863f-082b8dddee67?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64798803",
"date_amm": "2021-03-11",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1525",
"substance": "ADÉNOVIRUS TYPE 26 CODANT POUR LA GLYCOPROTÉINE SPIKE DU SARS-COV-2",
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "suspension injectable",
"voies_administration": "intramusculaire",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about adénovirus type 26 codant pour la glycoprotéine spike du sars-cov-2.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.